IP Library Granted Patent US 7,538,233
Granted Patent B2
US 7,538,233 · App. 10/925,292 · Granted May 26, 2009

Coumarins as iNOS inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,538,233
App. No.
10/925,292
Granted
May 26, 2009
Kind
B2
Abstract

The present invention relates to coumarins of the formula (I): that are useful as inhibitors of nitric oxide synthase. Pharmaceutical compositions and methods of using these compounds as inhibitors of nitric oxide synthase are described herein.

Claims (30)

1. A compound of formula (I):

wherein:

A is O,

R is selected from the group consisting of (CH 2 ) n NR 1 R 2 , wherein R 1 and R 2 are the same or different and are selected from the group consisting of hydrogen, C(═NH)NH 2 and C 1 -C 6 alkyl,

n is an integer of from 2-5;

X 1 is hydrogen

X 2 is hydrogen;

X 3 is halogen,

X 4 is hydrogen; and

X 5 is hydrogen

with the proviso that when n is 2, R 1 and R 2 are not both hydrogen or both ethyl and X 3 chlorine,

and the pharmaceutically acceptable salts and optical isomers thereof.

2. The compound according to claim 1 wherein:

A is O;

R is (CH 2 ) n NR 1 R 2 , and

X 3 is halogen.

3. The compound according to claim 2 wherein R 1 R 2 are selected from the group consisting of hydrogen, C 1-6 alkyl, and C(═NH)NH 2 .

4. The compound according to claim 3 wherein X 3 is selected from the group consisting of bromine and chlorine.

5. The compound according to claim 4 wherein the halogen is chlorine.

6. The compound according to claim 1 selected from the group consisting of:

6-Chloro-4-(3-aminopropoxy)-1-benzopyran-2-one,

6-Chloro-4-(3-methylamino-propoxy)-1-benzopyran-2-one,

4-(2-Amino-ethoxy)-6-chloro-1-benzopyran-2-one,

4-(3-Amino-propoxy)-6-bromo-1-benzopyran-2-one,

4-(3-Amino-propoxy)-6-fluoro-1-benzopyran-2-one,

6-Chloro-4-(3-dimethylamino-propoxy)-1-benzopyran-2-one,

N-[3-(6-Chloro-2-oxo-2H-1-benzopyran-4-yloxy)-propyl]-guanidine,

N-[3-(6-Chloro-2-oxo-2H-1-benzopyran-4-yloxy)-propyl]-acetamide,

4-(5-Amino-pentyloxy)-6-chloro- 1-benzopyran-2-one.

7. A pharmaceutical composition comprising an effective amount of a compound according to claim 6 and a pharmaceutical acceptable carrier.

Assignments (3)
MERGER Recorded Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →
CERTIFICATE OF CONVERSION Recorded Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034566/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2009
From: CHIANG, YULIN; MERRILL, JEAN; REBELLO, SAM S.; JACKSON, SHARON; NIEDUZAK, THADDEUS; LIANG, GUYAN
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 022536/0553 →